Offer - Urjas Oil for just ₹ 1 X
Hydrazide 25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Edema, High BP. Other than this, Hydrazide 25 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Hydrazide 25 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Hydrazide 25 Mg Tablet have been listed ahead. Normally, these side effects of Hydrazide 25 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Hydrazide 25 Mg Tablet's effect during pregnancy is Safe and Safe while nursing. In addition, Hydrazide 25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Hydrazide 25 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Asthma, Allergy, Kidney Disease must refrain from the use of Hydrazide 25 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Hydrazide 25 Mg Tablet are listed in the contraindications section below.
Drug interactions for Hydrazide 25 Mg Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Hydrazide 25 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Hydrazide 25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
13 - 18 years (Adolescent) |
|
Is the use of Hydrazide 25 Mg Tablet safe for pregnant women?
Hydrazide is safe to take during pregnancy.
Is the use of Hydrazide 25 Mg Tablet safe during breastfeeding?
Hydrazide is completely safe for breastfeeding women.
What is the effect of Hydrazide 25 Mg Tablet on the Kidneys?
Hydrazide rarely harms the kidneys.
What is the effect of Hydrazide 25 Mg Tablet on the Liver?
Side effects of Hydrazide rarely affect the liver.
What is the effect of Hydrazide 25 Mg Tablet on the Heart?
Hydrazide is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Hydrazide 25 Mg Tablet unless your doctor advises you to do so -
Is this Hydrazide 25 Mg Tablet habit forming or addictive?
No, you will not get addicted to Hydrazide 25 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Hydrazide 25 Mg Tablet. So it is best to avoid driving.
Is it safe?
Hydrazide 25 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Hydrazide 25 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Hydrazide 25 Mg Tablet
When consumed with certain foods, Hydrazide 25 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Hydrazide 25 Mg Tablet
Taking Hydrazide 25 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448